< Back to News
National Brain Tumor Society Invests in GBM AGILE, the World’s First Global Adaptive Trial for Glioblastoma
JANUARY 16, 2019 | NATIONAL BRAIN TUMOR SOCIETY
Copyright © 2018
Global Coalition for Adaptive Research.
All Rights Reserved.
The Global Coalition for Adaptive Research is registered as a 501(c)(3) nonprofit organization. Contributions to the Global Coalition for Adaptive Research are tax-deductible to the extent permitted by law.